Intranasal Administration of SARS-CoV-2 ORF8 Accessory Protein Increases Blood Pressure and Oxidative Stress in

Karla A Pavon-Martinez1,2, Giovani Visoso-Carvajal2, Rebeca Campi-Caballero1,2

  • 1Laboratorio Multidisciplinario en Ciencias Biomédicas, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Salvador Díaz Mirón s/n, Casco de Santo Tomás, Ciudad de México C.P. 11340, Mexico.

Viruses
|April 27, 2026
PubMed

Insights

SARS-CoV-2 accessory protein ORF8 impacts blood pressure and antioxidant systems. Long-term ORF8 exposure may cause kidney changes and cognitive dysfunction linked to COVID-19.

Area of Science:

  • Virology
  • Immunology
  • Pathophysiology

Background:

  • SARS-CoV-2 infection causes COVID-19, with the ORF8 accessory protein implicated in immune evasion and cytokine storms.
  • Oxidative stress is a proposed mechanism for viral pathogenicity, but ORF8's specific role is unclear.

Purpose of the Study:

  • To investigate the effects of intranasal Open Reading Frame 8 (ORF8) administration on arterial blood pressure and the antioxidant system in mice.
  • To assess long-term physiological changes induced by ORF8 exposure.

Main Methods:

  • Male BALB/c mice received intranasal ORF8.
  • Blood pressure and organ-specific antioxidant systems were evaluated at 2 and 8 weeks post-administration.

Main Results:

  • A significant increase in blood pressure and renal total antioxidant capacity was observed 8 weeks after ORF8 administration.
  • A decrease in catalase activity in the prefrontal cortex was noted 2 weeks after ORF8 administration.

Conclusions:

  • ORF8 administration can lead to sustained increases in blood pressure and altered renal antioxidant capacity.
  • ORF8 may contribute to cognitive dysfunction mechanisms relevant to COVID-19 and long-term renal alterations.

Related Concept Videos